Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 27, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on July 27, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 680 Common Stock at $525.81 ($357,552) on July 27, 2026; holds 333,263 after (Indirect).
- Open-market sale: disposed of 890 Common Stock at $527.14 ($469,152) on July 27, 2026; holds 332,373 after (Indirect).
- Open-market sale: disposed of 650 Common Stock at $528.51 ($343,530) on July 27, 2026; holds 331,723 after (Indirect).
- Open-market sale: disposed of 1,797 Common Stock at $529.75 ($951,959) on July 27, 2026; holds 329,926 after (Indirect).
- Open-market sale: disposed of 1,121 Common Stock at $530.49 ($594,675) on July 27, 2026; holds 328,805 after (Indirect).
- Open-market sale: disposed of 1,836 Common Stock at $531.65 ($976,107) on July 27, 2026; holds 326,969 after (Indirect).
- Open-market sale: disposed of 1,529 Common Stock at $532.38 ($814,004) on July 27, 2026; holds 325,440 after (Indirect).
- Open-market sale: disposed of 957 Common Stock at $533.53 ($510,590) on July 27, 2026; holds 324,483 after (Indirect).
- Open-market sale: disposed of 40 Common Stock at $535.04 ($21,402) on July 27, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on July 27, 2026; holds 265,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,038,971 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-07-27 | Open-market sale | Common Stock | 680 | $526 | $357.6K | 333,263 |
| 2026-07-27 | Open-market sale | Common Stock | 890 | $527 | $469.2K | 332,373 |
| 2026-07-27 | Open-market sale | Common Stock | 650 | $529 | $343.5K | 331,723 |
| 2026-07-27 | Open-market sale | Common Stock | 1,797 | $530 | $952.0K | 329,926 |
| 2026-07-27 | Open-market sale | Common Stock | 1,121 | $530 | $594.7K | 328,805 |
| 2026-07-27 | Open-market sale | Common Stock | 1,836 | $532 | $976.1K | 326,969 |
| 2026-07-27 | Open-market sale | Common Stock | 1,529 | $532 | $814.0K | 325,440 |
| 2026-07-27 | Open-market sale | Common Stock | 957 | $534 | $510.6K | 324,483 |
| 2026-07-27 | Open-market sale | Common Stock | 40 | $535 | $21.4K | 324,443 |
| 2026-07-27 | Option exercise/conversion | Stock Option | 9,500 | — | — | 265,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Option exercise/conversion (9,500 shares) |
| 2026-07-27 | Open-market sale (680 shares) |
| 2026-07-27 | Open-market sale (890 shares) |
| 2026-07-27 | Open-market sale (650 shares) |
| 2026-07-27 | Open-market sale (1,797 shares) |
| 2026-07-27 | Open-market sale (1,121 shares) |
| 2026-07-27 | Open-market sale (1,836 shares) |
| 2026-07-27 | Open-market sale (1,529 shares) |
| 2026-07-27 | Open-market sale (957 shares) |
| 2026-07-27 | Open-market sale (40 shares) |
| 2026-07-27 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.